Abstract
Heart failure is a progressive and fatal disease process. Arrhythmias and progressive cardiac dysfunction account for most of the morbidity and mortality in patients with heart failure. In general, the physiologic mechanisms responsible for progressive myocyte dysfunction, remodeling, and arrhythmias involve signaling mechanisms that alter myocardial gene expression. These changes in gene expression are complex and involve contractile proteins, ion channels, Ca++ handling, apoptosis, cell metabolism, the extracellular matrix, signal transduction pathways, and growth factors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Lowes BD, Minobe W, Abraham WT, et al.: Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997, 100:2315–2324.
Nakao K, Minobe W, Roden R, et al.: Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997, 100:2362–2370.
Miyata S, Minobe W, Bristow MR, Leinwand LA: Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 2000, 86:386–390.
Sucharov CC, Helmke SM, Langer SJ, et al.: The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression. Mol Cell Biol 2004, 24:8705–8715.
Lowes BD, Gill EA, Abraham WT, et al.: Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999, 83:1201–1205.
Lowes BD, Gilbert EM, Abraham WT, et al.: Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N EnglJ Med 2002, 346:1357–1365. This is a landmark paper that describes the role of fetal gene expression in contractile dysfunction and the effects of β-blockade on reversing this process.
Tomaselli GF, Beuckelmann DJ, Calking HG, et al.: Sudden death in cardiac failure: the role of abnormal repolarization. Circulation 1994, 90:2534–2539.
Tomaselli GF, Marban E: Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999, 42:270–283. This is a very well-written review on ion channels and mechanisms of arrhythmias in hypertrophy and heart failure.
Gwathmey JK, Copelas L, MacKinnon R, et al.: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987, 61:70–76.
Beuckelmann DJ, Nabauer M, Erdmann E: Alterations of K currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993, 73:379–385.
Nabauer M, Beuckelmann DJ, Uberfuhr P, et al.: Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 1996, 93:168–177.
Kaab S, Dixon J, Duc J, et al.: Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998, 98:1383–1393.
Nabauer M, Barth gnA, Kaab S: A second calcium-independent transient outward current present in human left ventricular myocardium. Circulation 1998,I-231.
Armoundas AA, Wu R, Juang G, et al.: Electrical and structural remodeling of the failing ventricle. Pharmacol Ther 2001, 92:213–230.
Studer R, Reinecke H, Bilger J, et al.: Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. Circ Res 1994, 75:443–453.
Flesch M, Schwinger RH, Schiffer F, et al.: Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation 1996, 94:992–1002.
Tomaselli GF, Rose J: Molecular aspects of arrhythmias associated with cardiomyopathies. Curr Opin Cardiol 2000, 15:202–208.
Hasenfuss G, Schillinger W, LehnartSE, et al.: Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 1999, 99:641–648.
Cerbai E, Pino R, Porciatti F, et al.: Characterization of the hyperpolarization-activated current, I(F), in ventricular myocytes from human failing heart. Circulation 1997, 95:568–571.
Borlak J, Thum T: Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J 2003, 17:1592–1608.
Hoppe UC, Sudkamp JE, Beuckelmann DJ: Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998, 97:55–65.
Cerbai E, Sartiani L, DePaoli P, et al.: The properties of the pacemaker current I (F) in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 2001, 33:441–448.
Harding JD, Piacentino V, Gaughan JP, et al.: Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001, 104:1241–1247.
Heerdt PM, Holmes JW, Cai B, et al.: Chronic unlading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 2000, 102:2713–2719.
Steenman M, Chen YW, Le Cunff M, et al.: Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 2003, 12:97–112.
Tan FL, Moravec CS, Li J, et al.: The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 2002, 99:11387–11392. This is an outstanding study that illustrates the power and limitations of a genomic-wide approach to gene expression analysis.
Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ: Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 2003, 41:1096–1106.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rivera, D.M., Lowes, B.D. Molecular remodeling in the failing human heart. Curr Heart Fail Rep 2, 5–9 (2005). https://doi.org/10.1007/s11897-005-0001-7
Issue Date:
DOI: https://doi.org/10.1007/s11897-005-0001-7